These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7194491)

  • 21. Inhibitory action of soluble elastin on thromboxane B2 formation in blood platelets.
    Sekiya K; Okuda H
    Biochim Biophys Acta; 1984 Mar; 797(3):348-53. PubMed ID: 6320905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of nonanal, trans-2-nonenal and 4-hydroxy-2,3-trans-nonenal on cyclooxygenase and 12-lipoxygenase metabolism of arachidonic acid in rabbit platelets.
    Sakuma S; Fujimoto Y; Tagano S; Tsunomori M; Nishida H; Fujita T
    J Pharm Pharmacol; 1997 Feb; 49(2):150-3. PubMed ID: 9055186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thromboxane synthase inhibition potentiates washed platelet activation by endogenous and exogenous arachidonic acid.
    Patscheke H
    Biochem Pharmacol; 1985 Apr; 34(8):1151-6. PubMed ID: 3922373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-alpha-Tosyl-L-lysine chloromethyl ketone and N-alpha-tosyl-L-phenylalanine chloromethyl ketone inhibit protein kinase C.
    Solomon DH; O'Brian CA; Weinstein IB
    FEBS Lett; 1985 Oct; 190(2):342-4. PubMed ID: 4043411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The formylpeptide chemotactic receptor on rabbit peritoneal neutrophils: change of receptor affinity and number by L-1-tosylamide-2-phenylethyl chloromethyl ketone (TPCK).
    Mackin WM; Becker EL
    Int J Immunopharmacol; 1983; 5(5):365-75. PubMed ID: 6317580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biosynthesis of thromboxane B2 and 12-L-hydroxy-5,8,10-heptadecatrienoic acid in human platelets. Evidence for a common enzymatic pathway.
    Raz A; Aharony D; Kenig-Wakshal R
    Eur J Biochem; 1978 May; 86(2):447-54. PubMed ID: 658053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A two-fold effect of L-1-tosylamide-2-phenylethyl chloromethyl ketone on the oxidative metabolism of guinea pig phagocytes.
    Dri P; Berton G; Patriarca P
    Inflammation; 1981 Sep; 5(3):223-39. PubMed ID: 7298162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human blood platelet behaviour after inhibition of thromboxane synthetase.
    Heptinstall S; Fox SC
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):31S-37S. PubMed ID: 6401998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time-dependent inhibition of the cyclooxygenase pathway by 12-hydroperoxy-5,8,10,14-eicosatetraenoic acid.
    Hashimoto Y; Naito C; Teramoto T; Kato H; Kinoshita M; Kawamura M; Hayashi H; Oka H
    Biochem Biophys Res Commun; 1985 Jul; 130(2):781-5. PubMed ID: 3927909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
    Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of platelet thromboxane synthetase by 1-(3-benzyloxy-1[E]octenyl)imidazole.
    Sincholle D; Coquelet C; Bonne C
    Arzneimittelforschung; 1986; 36(1):117-9. PubMed ID: 3082339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective inhibitors of platelet lipoxygenase: 4,7,10,13-eicosatetraynoic acid and 5,8,11,14-henicosatetraynoic acid.
    Wilhelm TE; Sankarappa SK; VanRollins M; Sprecher H
    Prostaglandins; 1981 Feb; 21(2):323-32. PubMed ID: 6784191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the synthetic inhibitor tosylamino-phenylethyl-chloromethylketone on chemotactic peptide receptor activation and superoxide production in human neutrophils.
    Suter S; Lew PD; Waldvogel FA
    Pediatr Res; 1986 Sep; 20(9):848-52. PubMed ID: 3018658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic activation by collagen and 15-hydroxy-9 alpha,11 alpha-peroxidoprosta-5,13-dienoic acid (PGH2) of phosphatidylinositol metabolism and arachidonic acid release in human platelets.
    Rittenhouse SE; Allen CL
    J Clin Invest; 1982 Dec; 70(6):1216-24. PubMed ID: 6816811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostaglandin H2 in human platelet activation: coactivator and substitute for thromboxane A2.
    Hornberger WB; Patscheke H
    Prog Clin Biol Res; 1989; 301():315-9. PubMed ID: 2798452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chloromethyl ketones block induction of nitric oxide synthase in murine macrophages by preventing activation of nuclear factor-kappa B.
    Kim H; Lee HS; Chang KT; Ko TH; Baek KJ; Kwon NS
    J Immunol; 1995 May; 154(9):4741-8. PubMed ID: 7536778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sphingomyelin inhibits platelet 12-lipoxygenase activity.
    Fujimoto Y; Sakuma S; Tsunomori M; Sumiya T; Fujita T
    Eur J Pharmacol; 1999 Aug; 378(2):233-6. PubMed ID: 10478636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Kinetic mechanisms of enzyme activity of the thromboxane synthetase system. Thromboxane synthetase of human platelets].
    Basevich VV; Mevkh AT; Varfolomeev SD
    Biokhimiia; 1984 Sep; 49(9):1538-45. PubMed ID: 6440597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of thromboxane and 12-HPETE formation by dazoxiben and its two thiophenic acid-substituted derivatives.
    Smith EF; Darius H; Ferber H; Schrör K
    Eur J Pharmacol; 1985 Jun; 112(2):161-9. PubMed ID: 3896821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.